摘要
Triggering receptor expressed on myeloid cells-1(TREM-1)is a member of the immunoglobulin superfamily.As an amplifier of the inflammatory response,TREM-1 is mainly involved in the production of inflammatory mediators and the regulation of cell survival.TREM-1 has been studied in infectious diseases and more recently in non-infectious disorders.More and more studies have shown that TREM-1 plays an important pathogenic role in kidney diseases.There is evidence that TREM-1 can not only be used as a biomarker for diagnosis of disease but also as a potential therapeutic target to guide the development of novel therapeutic agents for kidney disease.This review summarized molecular biology of TREM-1 and its signaling pathways as well as immune response in the progress of acute kidney injury,renal fibrosis,diabetic nephropathy,immune nephropathy,and renal cell carcinoma.
基金
supported by grants from the National Natural Science Foundation of China(Nos.82070776,82270796,82200849,and 82370761)
the Science and Technology Innovation Program of Hunan Province(No.2022RC3071)
the Natural Science Foundation of Hunan Province(No.2023JJ40872)
the Higher Education Teaching Reform Project of Central South University(No.2023jy110).
